Skip to main content
Sinocare Inc. logo

Sinocare Inc. — Investor Relations & Filings

Ticker · 300298 ISIN · CNE100001CJ0 LEI · 3003008DEKI00A51LU77 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,252 across all filing types
Latest filing 2017-12-14 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 300298

About Sinocare Inc.

https://www.sinocare.com

Sinocare Inc. specializes in the research, development, and manufacturing of biosensor technology and rapid testing products for chronic disease management. The company is primarily recognized for its blood glucose monitoring systems, including meters and test strips, which serve a global patient base. Its product portfolio extends to point-of-care testing (POCT) solutions for HbA1c, uric acid, blood lipids, and other metabolic indicators. Through the integration of advanced sensing technologies and digital health platforms, Sinocare provides comprehensive diagnostic tools for diabetes and related metabolic disorders. The company focuses on delivering affordable and accurate monitoring solutions to improve the quality of life for individuals with chronic conditions worldwide.

Recent filings

Filing Released Lang Actions
关于《三诺生物会后二次反馈意见》的回复
Capital/Financing Update Classification · 95% confidence The document is a detailed formal reply from SanNuo Biological Sensor Co., Ltd. to the China Securities Regulatory Commission regarding the second round of feedback on a report related to the issuance of shares to purchase assets. It discusses the procedures followed, compliance with regulations from the Ministry of Finance concerning state-owned financial enterprises, asset valuation and appraisal reports, and includes opinions from independent financial advisors and legal counsel. The content focuses on the procedural and regulatory compliance aspects of a major asset restructuring involving issuance of shares to purchase assets. This aligns with the characteristics of a Capital/Financing Update (CAP) filing, which covers updates on company fundraising, financing activities, or capital structure changes. The document is substantive and not merely an announcement or certification, and it does not fit into other categories such as Annual Report, Audit Report, or Regulatory Filings. Therefore, the appropriate classification is CAP with high confidence.
2017-12-14 Chinese
中信证券股份有限公司关于《三诺生物会后二次反馈意见》回复的核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed response from an independent financial advisor (中信证券股份有限公司) to the China Securities Regulatory Commission regarding follow-up feedback on a share issuance and asset purchase transaction involving 三诺生物. It discusses the verification of procedures, compliance with regulations on state-owned financial enterprise equity management, asset valuation reports, and internal decision-making processes related to the issuance of shares to purchase assets. The document includes detailed procedural and regulatory compliance information, valuation comparisons, and confirmations of internal approvals. It is not a full annual or interim financial report, nor is it a simple announcement or certification. It is a specialized verification and audit opinion related to the transaction and regulatory compliance, which fits the definition of an Audit Report / Information (AR). The document length (6670 characters) and content depth support this classification rather than a brief announcement or a full financial report.
2017-12-14 Chinese
北京国枫律师事务所关于公司发行股份购买资产并募集配套资金的补充法律意见书之六
Regulatory Filings
2017-12-14 Chinese
发行股份购买资产并募集配套资金报告书（修订稿）
Capital/Financing Update Classification · 95% confidence The document is titled as a report on "发行股份购买资产并募集配套资金报告书（修订稿）" which translates to "Report on Issuance of Shares to Purchase Assets and Raise Supporting Funds (Revised)". It details a major asset acquisition and related fundraising by 三诺生物传感股份有限公司 (Sannuo Biosensing Co., Ltd.). The content includes extensive sections on transaction parties, asset evaluation, financial data, risk factors, legal compliance, and management discussion and analysis. The document is lengthy (15,000 characters) and contains detailed financial and transactional information, not just an announcement or summary. This matches the characteristics of a Capital/Financing Update (CAP) filing, which covers company fundraising and capital structure changes related to asset purchases and share issuance. It is not an Annual Report, Interim Report, or Regulatory Filing, as it focuses on a specific transaction and capital raising event. Therefore, the correct classification is CAP with high confidence.
2017-12-14 Chinese
关于《并购重组委2017年第63次会议审核结果公告》的审核意见回复
M&A Activity Classification · 95% confidence The document is a detailed response from SanNuo Biological Sensor Co., Ltd. to the China Securities Regulatory Commission's (CSRC) Mergers and Acquisitions Committee's 2017 63rd meeting review results announcement. It discusses compliance, valuation, and fairness of a major asset restructuring involving share issuance and capital raising. The content includes detailed explanations about the use of raised funds, asset transfer plans, regulatory compliance, and valuation reports by independent financial advisors and appraisal firms. The document is focused on merger and acquisition activities, specifically addressing regulatory review comments on a major asset restructuring transaction. It is not a full annual or interim report, earnings release, or other financial report type. It is not a simple announcement or certification but a substantive reply to a regulatory review on a merger and acquisition transaction. Therefore, the document fits best under the category of M&A Activity (Code: TAR). The document length (12,660 characters) and detailed content support this classification with high confidence.
2017-11-23 Chinese
北京国枫律师事务所关于公司发行股份购买资产并募集配套资金的补充法律意见书之五
Regulatory Filings
2017-11-23 Chinese

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.